Evidence map›Paper›PMID 40496964›Full record

ArticlePublic health challenges2023

Enablers and barriers of COVID-19 vaccination efforts in Nepal.

Sunit Chhetri, Srista Manandar, Sunny Chhetri, Astha Acharya, Swapnil Regmi, Dil Bahadur Gurudhami, Thinley Dorji

Abstract read
In one paragraph

Article in Public health challenges, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sunit ChhetriDepartment of Internal Medicine B.P. Koirala Institute of Health Sciences Dharan Nepal.ORCID https://orcid.org/0000-0003-4704-0272
Srista ManandarDepartment of Internal Medicine B.P. Koirala Institute of Health Sciences Dharan Nepal.ORCID https://orcid.org/0000-0001-8240-2254
Sunny ChhetriDepartment of Internal Medicine B.P. Koirala Institute of Health Sciences Dharan Nepal.
Astha AcharyaDepartment of Internal Medicine B.P. Koirala Institute of Health Sciences Dharan Nepal.
Swapnil RegmiDepartment of Internal Medicine B.P. Koirala Institute of Health Sciences Dharan Nepal.
Dil Bahadur GurudhamiDepartment of Internal Medicine B.P. Koirala Institute of Health Sciences Dharan Nepal.
Thinley DorjiDepartment of Internal Medicine Central Regional Referral Hospital Gelegphu Bhutan.ORCID https://orcid.org/0000-0003-4932-8704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nepal, a landlocked country with a population of 29.1 million faced great socioeconomic, financial, and social hardships during the Coronavirus disease 2019 (COVID-19) pandemic. Nepal had increasing cases of COVID-19 despite multiple lockdowns and travel restrictions. Nepal reported 1,000,775 cases and 12,019 deaths till early November 2022. Timely government decisions, strategic political diplomacy, flexible vaccine policy, and multiple loan deals helped Nepal secure the COVID-19 vaccine from India in a commendable time frame. With the existing structure of the primary health care settings and experience of having implemented childhood vaccination campaigns, Nepal rolled out the COVID-19 vaccines across the nation on 27 January 2021. However, the delta wave was a devastating blow to South Asia with a high number of hospitalizations and deaths and a complete disruption of the COVID-19 vaccine supply from India. The government ran a relentless effort in COVID-19 vaccination and provided full vaccination to 33% of the total population by the end of 2021 and 81.1% by May 2022. The booster doses were administered beginning in 2022, but the campaign efforts have been lethargic with a coverage of only 29.2% and a lack of keen support from the public. The emergence of new variants of the virus continues to pose a challenge in controlling the disease and reopening the country to pre-pandemic levels of socioeconomic activities.

Indexed as

COVID‐19health‐care financingimmunizationNepalpandemicSARS‐CoV‐2vaccine development

Identifiers

PMID40496964
PMCPMC12039702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.